DarioHealth Corp. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
DarioHealth Corp. (DRIO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 919.81 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- DarioHealth Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 919.81K shares, a 76.56% decline year-over-year.
- DarioHealth Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 919.81K shares, a 73.37% decline year-over-year.
- DarioHealth Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 4.28M shares, a 140.55% increase year-over-year.
- DarioHealth Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 3.92M shares, a 88.38% decline year-over-year.
- DarioHealth Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 3.09M shares, a 73.22% increase from fiscal 2024.
- DarioHealth Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.78M shares, a 85.37% decline from fiscal 2023.
- DarioHealth Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 12.19M shares, a 112.17% increase from fiscal 2022.
- DarioHealth Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.74M shares, a 15.68% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 919.81K shares 10-Q · filed 2026-08-11 | 919.81K shares 10-Q · filed 2026-08-11 | ||||||
| 2026-03-31 | 919.81K shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 3.09M shares 10-K · filed 2026-03-19 | |||||||
| 2025-09-30 | 4.28M shares 10-Q · filed 2025-11-13 | 4.06M shares 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | 3.92M shares 10-Q · filed 2026-08-11 | 78.49M shares 10-Q · filed 2025-08-12 | 3.75M shares 10-Q · filed 2026-08-11 | 75.02M shares 10-Q · filed 2025-08-12 | ||||
| 2025-03-31 | 3.45M shares 10-Q · filed 2026-05-13 | 69.07M shares 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | 1.78M shares 10-K · filed 2026-03-19 | 35.67M shares 10-K · filed 2025-03-10 | ||||||
| 2024-09-30 | 1.78M shares 10-Q · filed 2025-11-13 | 35.63M shares 10-Q · filed 2024-11-07 | 1.72M shares 10-Q · filed 2025-11-13 | 34.34M shares 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | 33.78M shares 10-Q · filed 2025-08-12 | 32.88M shares 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | 26.68M shares 10-Q · filed 2025-05-14 | |||||||
| 2023-12-31 | 12.19M shares 10-K · filed 2025-03-10 | |||||||
| 2023-09-30 | 12.55M shares 10-Q · filed 2024-11-07 | 12.55M shares 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | 12.20M shares 10-Q · filed 2024-08-08 | 12.20M shares 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | 5.66M shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 5.74M shares 10-K · filed 2024-03-28 | |||||||
| 2022-09-30 | 6.80M shares 10-Q · filed 2023-11-02 | |||||||
| 2022-06-30 | 7.20M shares 10-Q · filed 2023-08-10 | |||||||
| 2022-03-31 | 6.74M shares 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | 6.81M shares 10-K · filed 2023-03-09 | 7.16M shares 10-K · filed 2022-03-22 | ||||||
| 2021-09-30 | 5.99M shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 5.75M shares 10-Q · filed 2022-08-15 | |||||||
| 2020-12-31 | 6.64M shares 10-K · filed 2022-03-22 | 7.82M shares 10-K · filed 2021-03-09 | ||||||
| 2019-12-31 | 6.55M shares 10-K · filed 2021-03-09 | |||||||
| 2018-12-31 | 997.91K shares 10-K · filed 2020-03-17 | 1.79M shares 10-K · filed 2019-03-25 | ||||||
| 2017-12-31 | 1.43M shares 10-K · filed 2019-03-25 | |||||||
| 2016-12-31 | 3.21M shares 10-K · filed 2018-03-19 | |||||||
| 2015-12-31 | 1.03M shares 10-K · filed 2017-03-22 | 18.48M shares 10-K · filed 2016-02-08 | ||||||
| 2014-12-31 | 8.24M shares 10-K · filed 2016-02-08 | |||||||
| 2013-12-31 | 2.17M shares 10-K · filed 2015-03-24 | 10.86M shares 10-K · filed 2014-03-04 | ||||||
| 2012-12-31 | 4.56M shares 10-K · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |